Skip to content

Drug interactions

Dihydroergotamine intranasal + Posaconazole

Severity: Contraindicated

Dihydroergotamine intranasal and Posaconazole: contraindicated interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Posaconazole can substantially increase systemic dihydroergotamine levels after intranasal dosing. This raises the risk of serious vasospastic ischemia of the extremities and central nervous system.

What this interaction means in plain words

Dihydroergotamine intranasal and Posaconazole are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Evidence level: High

Why it happens

Posaconazole strongly inhibits CYP3A4-mediated clearance of dihydroergotamine.

What to do

Avoid the combination; it is contraindicated in labeling. Choose a non-ergot acute migraine therapy during posaconazole treatment.

What to ask your pharmacist

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dihydroergotamine intranasal and Posaconazole, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dihydroergotamine intranasal with Posaconazole?

MediHelp rates the interaction as contraindicated. Dihydroergotamine intranasal and Posaconazole are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Posaconazole can substantially increase systemic dihydroergotamine levels after intranasal dosing. This raises the risk of serious vasospastic ischemia of the extremities and central nervous system.

How serious is the interaction between Dihydroergotamine intranasal and Posaconazole?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination; it is contraindicated in labeling. Choose a non-ergot acute migraine therapy during posaconazole treatment.

What other medicines interact with Posaconazole?

MediHelp also lists interactions of Posaconazole with, for example, Artemether, Avanafil, Cobimetinib. The full list is on the Posaconazole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in